ATE504594T1 - Sezernierte und zelloberflächengene, die in gutartigen und bösartigen kolorektaltumoren exprimiert werden - Google Patents

Sezernierte und zelloberflächengene, die in gutartigen und bösartigen kolorektaltumoren exprimiert werden

Info

Publication number
ATE504594T1
ATE504594T1 AT02773302T AT02773302T ATE504594T1 AT E504594 T1 ATE504594 T1 AT E504594T1 AT 02773302 T AT02773302 T AT 02773302T AT 02773302 T AT02773302 T AT 02773302T AT E504594 T1 ATE504594 T1 AT E504594T1
Authority
AT
Austria
Prior art keywords
rdp
benign
secreted
cell surface
genes expressed
Prior art date
Application number
AT02773302T
Other languages
German (de)
English (en)
Inventor
Phillip Buckhaults
Kenneth Kinzler
Bert Vogelstein
Original Assignee
Univ Johns Hopkins Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins Med filed Critical Univ Johns Hopkins Med
Application granted granted Critical
Publication of ATE504594T1 publication Critical patent/ATE504594T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/495Transforming growth factor [TGF]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Walking Sticks, Umbrellas, And Fans (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT02773302T 2001-09-07 2002-09-09 Sezernierte und zelloberflächengene, die in gutartigen und bösartigen kolorektaltumoren exprimiert werden ATE504594T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31749401P 2001-09-07 2001-09-07
US38380502P 2002-05-30 2002-05-30
PCT/US2002/028518 WO2003022863A1 (en) 2001-09-07 2002-09-09 Secreted and cell surface genes expressed in benign and malignant colorectal tumors

Publications (1)

Publication Number Publication Date
ATE504594T1 true ATE504594T1 (de) 2011-04-15

Family

ID=26980985

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02773302T ATE504594T1 (de) 2001-09-07 2002-09-09 Sezernierte und zelloberflächengene, die in gutartigen und bösartigen kolorektaltumoren exprimiert werden

Country Status (6)

Country Link
US (1) US8029764B2 (https=)
EP (1) EP1430071B1 (https=)
JP (1) JP2005518781A (https=)
AT (1) ATE504594T1 (https=)
DE (1) DE60239690D1 (https=)
WO (1) WO2003022863A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6927212B2 (en) * 2002-07-27 2005-08-09 The Johns Hopkins University Design and synthesis of renal dipeptidase inhibitors
WO2006066916A1 (en) * 2004-12-23 2006-06-29 Roche Diagnostics Gmbh Use of microsomal dipeptidase as a marker for colorectal cancer
US8217222B2 (en) 2005-09-30 2012-07-10 Anticancer, Inc. Methods for identifying markers for early-stage human cancer, cancer progression and recurrence
CN101971033A (zh) * 2007-06-04 2011-02-09 戴诺普雷克斯公司 用于结直肠癌的生物标志物组合
AU2010310468A1 (en) 2009-10-23 2012-05-24 Mannkind Corporation Cancer immunotherapy and method of treatment
WO2015138879A1 (en) * 2014-03-13 2015-09-17 Massachusetts Institute Of Technology Compositions containing pufa, uridine and choline and methods of use thereof
US20160209415A1 (en) * 2015-01-20 2016-07-21 Poochon Scientific LLC Method to predict or diagnose a colorectal cancer
WO2016164815A1 (en) 2015-04-10 2016-10-13 Applied Proteomics, Inc. Protein biomarker panels for detecting colorectal cancer and advanced adenoma
CN105603093A (zh) * 2016-02-05 2016-05-25 广州复能基因有限公司 以MIC-1 cDNA为模板制备RNA探针的方法
CN109402119A (zh) * 2018-12-11 2019-03-01 宁夏医科大学总医院 一种环状RNA hsa_circTGFBI_001及其特异性扩增引物和应用
CN109402125A (zh) * 2018-12-11 2019-03-01 宁夏医科大学总医院 一种环状RNA hsa_circTGFBI_007及其特异性扩增引物和应用
CN114428172A (zh) * 2022-01-20 2022-05-03 中山大学附属第六医院 用于预测结直肠癌患者术后远处转移风险的标志物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6333152B1 (en) 1997-05-21 2001-12-25 The Johnshopkins University Gene expression profiles in normal and cancer cells

Also Published As

Publication number Publication date
EP1430071A4 (en) 2005-11-02
WO2003022863A1 (en) 2003-03-20
US20040265824A1 (en) 2004-12-30
US8029764B2 (en) 2011-10-04
DE60239690D1 (de) 2011-05-19
JP2005518781A (ja) 2005-06-30
EP1430071B1 (en) 2011-04-06
EP1430071A1 (en) 2004-06-23

Similar Documents

Publication Publication Date Title
ATE504594T1 (de) Sezernierte und zelloberflächengene, die in gutartigen und bösartigen kolorektaltumoren exprimiert werden
WO2002009573A3 (en) Prognostic classification of endometrial cancer
WO2004060302A3 (en) Methods and compositions for the diagnosis, prognosis, and treatment of cancer
Ross et al. Recurrence and survival after surgical management of rectal cancer
EP2062918A3 (en) Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
WO1998053319A3 (en) Gene expression profiles in normal and cancer cells
WO2004027432A3 (en) Prognostic methods for patients with prostatic disease
AU2001249503A1 (en) High specificity marker detection
WO2002010436A3 (en) Prognostic classification of breast cancer
WO2001094629A8 (en) Cancer gene determination and therapeutic screening using signature gene sets
AU2001229340A1 (en) Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
AU2004205878A8 (en) Gene expression markers for breast cancer prognosis
WO2006047483A3 (en) Dynamic genomic deletion expansion and formulation of molecular marker panels for integrated molecular pathology diagnosis and characterization of tissue, cellular fluid, and pure fluid specimens
EP2431743A3 (en) Cancer specific glycans and use thereof
WO2005100608A3 (en) Diagnostic tool for diagnosing benign versus malignant thyroid lesions
WO2002081749A3 (en) Detection of aberrant dna methylation as marker for human cancer
WO2002021996A3 (en) Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators
WO2000055633A3 (en) Methods of screening for colorectal cancer modulators
Saran et al. Genetics of bladder cancer
AU2001290949A1 (en) Id-1 and id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma
WO2002076286A3 (en) Prognostic methods for breast cancer
EP1048740A3 (en) Methods and probe sets for determining prostate cancer prognosis
AU2596901A (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
AU5302599A (en) Method for diagnosing bone metastasis of malignant tumor
WO2004084804A3 (en) Detection and monitoring of lung cancer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties